Microdosing psychedelics shows promise for improving mindfulness in adults with ADHD
Adults with attention deficit hyperactivity disorder (ADHD) or severe ADHD symptoms who practiced microdosing with psychedelics reported increases in mindfulness after four weeks, according to new preliminary research published in Frontiers in Psychiatry. The findings underscore the importance of conducting future placebo-controlled studies to validate whether these observed changes can be replicated in a controlled experimental environment.
Other Articles in this Edition
People taking ADHD medications should closely monitor their heart health, study suggests
Psychiatric Comorbidity Increases Risk for Schizophrenia With ADHD
New study sheds light on ADHD’s impact on motivation and the efficacy of amphetamine-based meds
Microdosing psychedelics shows promise for improving mindfulness in adults with ADHD
Texas AG sues Pfizer over quality-control lapses in kids’ ADHD drug
US Limit on a Key ADHD Drug Is Worsening Shortages, Group Says
Diagnosed With ADHD — What Should I Do Now?
What it’s like to be diagnosed with ADHD as an adult in China